Antiviral effect of peginterferon alfa-2b and alfa-2a compared
- 作者Peter L.M. Jansen; Henk W. Reesink
- 卷第45卷
- 期第2期
- 印刷ISSN0168-8278
- 文件大小71.86KB
- 发表时间2006
- DOI10.1016/j.jhep.2006.06.003
A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritisYoo, Dae Hyun; Suh, Chang-Hee; Shim, Seung Cheol; Jeka, Slawomir; Cons-Molina, Francisco Fidencio; Hrycaj, Pawel; Wiland, Piotr; Lee, Eun Young; Medina-Rodriguez, Francisco G; Shesternya, Pavel; Radominski, Sebastiao; Stanislav, Marina; Kovalenko, Volodymyr; Sheen, Dong Hyuk; Myasoutova, Leysan; Lim, Mie Jin; Choe, Jung-Yoon; Lee, Sang Joon; Lee, Sung Young; Kwon, Taek Sang; Park, Won · Annals of the Rheumatic Diseases · 2017
P679 Development of a novel auto-injector of subcutaneous CT-P13 infliximab: Phase I randomised, open-label, single-dose trial to compare the pharmacokinetics and safety to pre-filled syringe in healthy subjectsSchreiber, S; Ben-Horin, S; Ye, B D; Westhovens, R; Yoo, D H; Lee, S J; Suh, J H; Byeon, J H; Reinisch, W · Journal of Crohn's and Colitis · 2019